PKCdelta in Insulin Secreting Cells 44. Rossig L, Badorff C, Holzmann Y, Zeiher AM, Dimmeler S (2002) Glycogen synthase kinase-3 couples AKT-dependent signaling to the regulation of p21Cip1 degradation. J Biol Chem 277: 9684–9689. 45. Li Y, Dowbenko D, Lasky LA (2002) AKT/PKB phosphorylation of p21Cip/ WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival. J Biol Chem 277: 11352–11361. 46. Scott MT, Ingram A, Ball KL (2002) PDK1-dependent activation of atypical PKC leads to degradation of the p21 tumour modifier protein. EMBO J 21: 6771–6780. 47. Janicke RU, Sohn D, Essmann F, Schulze-Osthoff K (2007) The multiple battles fought by anti-apoptotic p21. Cell Cycle 6: 407–413. 48. Schneider L, Essmann F, Kletke A, Rio P, Hanenberg H, et al. (2008) TACC3 depletion sensitizes to paclitaxel-induced cell death and overrides p21WAF- mediated cell cycle arrest. Oncogene 27: 116–125. 49. Asada M, Yamada T, Ichijo H, Delia D, Miyazono K, et al. (1999) Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation. EMBO J 18: 1223–1234. 50. Huang S, Shu L, Dilling MB, Easton J, Harwood FC, et al. (2003) Sustained activation of the JNK cascade and rapamycin-induced apoptosis are suppressed by p53/p21(Cip1). Mol Cell 11: 1491–1501. 51. Luo Y, Hurwitz J, Massague J (1995) Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1. Nature 375: 159–161. 52. Ullrich S, Berchtold S, Ranta F, Seebohm G, Henke G, et al. (2005) Serum- and Glucocorticoid-Inducible Kinase 1 (SGK1) Mediates Glucocorticoid-Induced Inhibition of Insulin Secretion. Diabetes 54: 1090–1099. 53. Ranta F, Avram D, Berchtold S, Du¨ fer M, Drews G, et al. (2006) Dexamethasone induces cell death in insulin secreting cells, an effect reversed by Exendin-4. Diabetes 55: 1380–1390. PLoS ONE | www.plosone.org 11 December 2011 | Volume 6 | Issue 12 | e28828